October Newsmakers

T Cells Take on Cancer (US News & World Report)
Features Matthias Gromeier, MD

She Watched Her Mother Suffer Quietly. Now She’s Helping Cancer Survivors Find Help (NBC News)
Features Eun-Ok Im, PhD, MPH, RN, CNS, FAAN

Piling on Drugs to Treat HER2-Positive Breast Cancer (Cure)
Features Kimberly Blackwell, MD

Neurosurgeon John Sampson named to the National Academy of Medicine (Duke Health News)
Features John Sampson, MD, PhD

On the Record (WRAL
Features Gretchen Kimmick, MD

Birthwort Cancer Risk: People Are Still Eating One of the Most Dangerous Plants on Earth As a Traditional Medicine (Newsweek)
Features Steve Rozen, PhD

Scientists reveal herbal remedies containing aristolochic acid may cause liver cancer (Duke-NUS Medical School)
Features Steve Rozen, PhD

The Basics Behind Bladder Cancer Treatment Gains (Cure)
Features Brant Inman, MD, MS

Community engagement, partnerships can reduce cancer disparities, improve population health (Healio)
Features Nadine J. Barrett, PhD

Light-Based Cancer Therapy Moves Through Clinical Trials (Pratt School of Engineering)
Features Neil Spector, MD 

Expert Discusses Optimizing Sequence of Non-Hormonal Therapy in mCRPC (OncLive)
Features Daniel George, MD

Expert Highlights Biological Advancements in Bladder Cancer Field (OncLive)
Features Daniel George, MD

Expert Highlights Biological Advancements in Bladder Cancer Field (OncLive)
Features Brant Inman, MD, MS

WATCH: Dr. Zhang on the Impact of the LATITUDE Study in Prostate Cancer (OncLive)
Features Tian Zhang, MD

Phase III Data Show Benefit With Abiraterone in Castration-Sensitive Prostate Cancer (OncLive)
Features Tian Zhang, MD

Advanced RCC Results Point to Potentially New Frontline Treatments (OncLive)
Michael Harrison, MD

Novel Imaging Techniques Advancing Prostate Cancer Care (OncLive)
Features William R. Berry, MD

WATCH: Dr. LeBlanc on Incorporating Palliative Care in the Treatment of Hematologic Malignancies (OncLive
Features Thomas LeBlanc, MD

WATCH: Dr. LeBlanc Discusses End-of-LIfe Care for Hematologic Malignancies (OncLive
Features Thomas LeBlanc, MD

Precision Medicine Has Emerging Role in mCRPC (OncLive)
Features Andrew Armstrong, MD

Could studying dogs crack the cure to cancer for humans? (ABC 11)
Features Michael Kastan, MD, PhD

Blue Devil of the Week: Providing Support to Cancer Patients (Duke Today)  
Features Kristy Everette 

The World Journal of Surgery Announces Julie Ann Sosa, MD MA FACS, as Editor-in-Chief (World Journal of Surgery)
Features Julie Ann Sosa, MD

New study assesses precision medicine (Yale News)
Features Warren Kibbe, PhD

OncLive Welcomes New Members to the Advisory Board for Giants of Cancer Care (BusinessWire)
Features Daniel George, MD

Cancer and canine: Triangle researchers use dogs to find better tumor treatment (The Chronicle)
Features Mark Dewhirst DVM, PhD

Poliovirus treatment mechanism revealed in new Duke study (The Chronicle)
Features Matthias Gromeier

Complementary Therapies for Cancer Treatment Are Coming of Age (Cure)
Features Duke Cancer Institute

UConn Health collaborating with Duke to help cancer patients (WTNH)
Features The Preston Robert Tisch Brain Tumor Center


Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells. Cancer Lett. (2017 Sep 28). Oladapo HO, Tarpley M, Sauer SJ, Addo KA, Ingram SM, Strepay D, Ehe BK, Chdid L, Trinkler M, Roques JR, Darr DB, Fleming JM, Devi GR, Williams KP.  PMID: 28965853